PCN52 ABIRATERONE VERSUS ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.249
https://www.valueinhealthjournal.com/article/S1098-3015(19)32627-0/fulltext
Title : PCN52 ABIRATERONE VERSUS ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32627-0&doi=10.1016/j.jval.2019.09.249
First page :
Section Title :
Open access? : No
Section Order : 10197
Categories :
Tags :
Regions :
ViH Article Tags :